MITOTANE

MITOTANE was reported 1830 times

MITOTANE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADRENOCORTICAL CARCINOMA 24 0.2727
1 CORTISOL FREE URINE ABNORMAL 1 0.1667
2 MINERALOCORTICOID DEFICIENCY 4 0.1538
3 PSEUDOPRECOCIOUS PUBERTY 3 0.1304
4 METASTATIC PULMONARY EMBOLISM 1 0.1000
5 PARAPHARYNGEAL ABSCESS 1 0.1000
6 GINGIVAL POLYP 1 0.0909
7 MELANODERMIA 2 0.0588
8 MIXED RECEPTIVE-EXPRESSIVE LANGUAGE DISORDER 1 0.0556
9 CENTRAL HYPOTHYROIDISM 17 0.0514
10 DRUG LEVEL THERAPEUTIC 1 0.0455
11 ADRENAL GLAND CANCER METASTATIC 3 0.0441
12 ADRENAL CARCINOMA 2 0.0426
13 TRIGEMINAL NEURITIS 1 0.0417
14 DRUG CLEARANCE INCREASED 9 0.0404
15 HYPERADRENOCORTICISM 11 0.0400
16 PELIOSIS HEPATIS 5 0.0347
17 LEGIONELLA TEST POSITIVE 1 0.0323
18 ADRENAL ATROPHY 2 0.0323
19 CHEMOTHERAPEUTIC DRUG LEVEL ABOVE THERAPEUTIC 2 0.0323
20 INTESTINAL TRANSIT TIME INCREASED 1 0.0312
21 PYOTHORAX 3 0.0234
22 ADRENALECTOMY 2 0.0204
23 ADRENOCORTICAL INSUFFICIENCY ACUTE 38 0.0195
24 HEPATIC RUPTURE 4 0.0179
25 PRECOCIOUS PUBERTY 10 0.0175
26 POST EMBOLISATION SYNDROME 2 0.0174
27 OVARIAN CYST TORSION 1 0.0169
28 LICHEN PLANUS PEMPHIGOIDES 1 0.0167
29 CYTOREDUCTIVE SURGERY 1 0.0161
30 SUPERIOR VENA CAVA OCCLUSION 2 0.0157
31 HYPOALDOSTERONISM 4 0.0146
32 SUBDURAL HAEMATOMA EVACUATION 1 0.0133
33 HEPATIC ISCHAEMIA 4 0.0129
34 PRIMARY HYPOGONADISM 2 0.0127
35 RABBIT SYNDROME 2 0.0120
36 ADRENAL INSUFFICIENCY 134 0.0110
37 DEHYDROEPIANDROSTERONE DECREASED 1 0.0101
38 PRIMARY ADRENAL INSUFFICIENCY 3 0.0098
39 POST PROCEDURAL VOMITING 1 0.0096
40 CORTISOL INCREASED 6 0.0096
41 HYPERCORTICOIDISM 1 0.0094
42 HEPATIC CANCER METASTATIC 8 0.0093
43 PIGMENTATION LIP 1 0.0093
44 AUTOIMMUNE THYROID DISORDER 1 0.0092
45 PANCREATIC PSEUDOCYST 7 0.0090
46 POST PROCEDURAL NAUSEA 1 0.0088
47 HYPOGONADISM MALE 2 0.0086
48 NEUROPATHIC PAIN 1 0.0085
49 HYPERTROPHY OF TONGUE PAPILLAE 1 0.0083
50 HYPOGONADISM 7 0.0069
51 RASH PAPULOSQUAMOUS 1 0.0066
52 SMALL INTESTINAL ULCER HAEMORRHAGE 1 0.0066
53 HAEMORRHOIDS THROMBOSED 2 0.0066
54 EPIPHYSES PREMATURE FUSION 2 0.0066
55 PRIMARY HYPERALDOSTERONISM 1 0.0064
56 ADRENAL NEOPLASM 3 0.0064
57 HEPATIC VEIN OCCLUSION 1 0.0063
58 BLOOD LACTIC ACID DECREASED 1 0.0058
59 WEANING FAILURE 2 0.0055
60 HEPATIC INFARCTION 2 0.0053
61 INTENTION TREMOR 3 0.0053
62 HERPES SIMPLEX REACTIVATION 2 0.0052
63 DRUG LEVEL ABOVE THERAPEUTIC 24 0.0052
64 SUSPECTED DRUG-INDUCED LIVER INJURY 1 0.0050
65 TUMOUR EXCISION 4 0.0050
66 BLEEDING TIME PROLONGED 6 0.0050
67 ENDOMETRIAL HYPERPLASIA 4 0.0049
68 TUMOUR NECROSIS 5 0.0047
69 DRUG CLEARANCE DECREASED 6 0.0046
70 SELF-INDUCED VOMITING 1 0.0046
71 PHARYNGOTONSILLITIS 1 0.0044
72 ORAL PUSTULE 1 0.0043
73 IMMUNE-MEDIATED PNEUMONITIS 1 0.0043
74 SYMPTOM MASKED 3 0.0041
75 OESOPHAGEAL SQUAMOUS CELL CARCINOMA 1 0.0041
76 ENTEROBACTER TEST POSITIVE 1 0.0041
77 INFESTATION 1 0.0039
78 RETINITIS PIGMENTOSA 1 0.0038
79 BLOOD CORTISOL INCREASED 1 0.0038
80 RETINOGRAM ABNORMAL 1 0.0037
81 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 1 0.0037
82 HAEMORRHAGIC INFARCTION 2 0.0036
83 THYROXINE FREE DECREASED 2 0.0035
84 SECONDARY HYPERTENSION 1 0.0035
85 BLOOD CORTICOTROPHIN INCREASED 1 0.0035
86 HYPOURICAEMIA 1 0.0034
87 HYPERLEUKOCYTOSIS 3 0.0034
88 SUPERIOR VENA CAVA SYNDROME 2 0.0033
89 DYSMETRIA 2 0.0033
90 ADNEXAL TORSION 1 0.0032
91 GASTROINTESTINAL TOXICITY 15 0.0031
92 INFUSION SITE REACTION 9 0.0030
93 BILIARY CIRRHOSIS PRIMARY 1 0.0029
94 ANDROGEN DEFICIENCY 1 0.0028
95 SMALL CELL LUNG CANCER METASTATIC 1 0.0028
96 ORCHITIS 3 0.0028
97 GLOMERULONEPHRITIS PROLIFERATIVE 1 0.0028
98 ACUTE PHASE REACTION 1 0.0026
99 LIPID METABOLISM DISORDER 1 0.0026
100 B PRECURSOR TYPE ACUTE LEUKAEMIA 1 0.0026
101 ADRENAL GLAND CANCER 1 0.0026
102 RENAL SALT-WASTING SYNDROME 1 0.0026
103 NEUTROPHILIC DERMATOSIS 1 0.0025
104 BONE DENSITY INCREASED 1 0.0025
105 IMMUNE-MEDIATED HEPATITIS 5 0.0024
106 ALTERED VISUAL DEPTH PERCEPTION 2 0.0024
107 GASTROINTESTINAL CANDIDIASIS 1 0.0024
108 PYRAMIDAL TRACT SYNDROME 1 0.0024
109 TWIN PREGNANCY 2 0.0024
110 FEEDING INTOLERANCE 1 0.0022
111 HYPERCHOLESTEROLAEMIA 21 0.0022
112 NEUROLOGICAL EXAMINATION ABNORMAL 1 0.0021
113 MENINGISM 1 0.0021
114 PATIENT UNCOOPERATIVE 1 0.0021
115 CEREBELLAR ATAXIA 2 0.0021
116 HYPOVOLAEMIC SHOCK 10 0.0021
117 BLOOD URIC ACID DECREASED 1 0.0021
118 AMNESTIC DISORDER 1 0.0021
119 GROWTH RETARDATION 6 0.0020
120 METASTASES TO ABDOMINAL CAVITY 1 0.0020
121 IMMUNE-MEDIATED THYROIDITIS 1 0.0020
122 LENTIGO 1 0.0020
123 MUCOSAL DISORDER 2 0.0020
124 SENSORIMOTOR DISORDER 1 0.0020
125 METASTASES TO PERITONEUM 5 0.0020
126 POST PROCEDURAL DIARRHOEA 1 0.0020
127 TRI-IODOTHYRONINE DECREASED 1 0.0019
128 OVARIAN FAILURE 1 0.0019
129 EXECUTIVE DYSFUNCTION 1 0.0018
130 EPIGLOTTITIS 1 0.0018
131 THROMBOCYTHAEMIA 1 0.0018
132 REPETITIVE SPEECH 1 0.0018
133 PRODUCT USE COMPLAINT 28 0.0018
134 LEGIONELLA INFECTION 1 0.0017
135 HAEMORRHAGIC OVARIAN CYST 1 0.0017
136 CYSTITIS HAEMORRHAGIC 7 0.0017
137 FOLATE DEFICIENCY 2 0.0017
138 MALNUTRITION 19 0.0017
139 ANTEROGRADE AMNESIA 1 0.0017
140 HEPATORENAL FAILURE 1 0.0017
141 BLOOD PRESSURE INADEQUATELY CONTROLLED 10 0.0017
142 FEBRILE BONE MARROW APLASIA 7 0.0016
143 SUSPECTED PRODUCT QUALITY ISSUE 3 0.0016
144 HELICOBACTER GASTRITIS 2 0.0016
145 DIAPHRAGMATIC HERNIA 1 0.0016
146 ABDOMINAL ABSCESS 7 0.0016
147 ANAL INFLAMMATION 1 0.0016
148 BLOOD CORTISOL DECREASED 1 0.0016
149 OVARIAN CYST RUPTURED 2 0.0016
150 HYPOTRICHOSIS 1 0.0016
151 HYPERTRIGLYCERIDAEMIA 9 0.0015
152 CYTOLYTIC HEPATITIS 5 0.0015
153 HIRSUTISM 2 0.0015
154 NEURODEVELOPMENTAL DISORDER 1 0.0015
155 T-LYMPHOCYTE COUNT DECREASED 1 0.0015
156 DRUG LEVEL BELOW THERAPEUTIC 8 0.0014
157 CUSHING'S SYNDROME 1 0.0014
158 HYPERTRANSAMINASAEMIA 10 0.0014
159 CERVIX DISORDER 1 0.0014
160 METASTASES TO LUNG 16 0.0014
161 LIP EROSION 1 0.0014
162 HAEMATOTOXICITY 13 0.0014
163 TRAUMATIC FRACTURE 1 0.0014
164 APRAXIA 2 0.0013
165 SCOTOMA 1 0.0013
166 NEPHRECTOMY 2 0.0013
167 DELUSIONAL DISORDER, UNSPECIFIED TYPE 1 0.0013
168 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
169 THERAPEUTIC PRODUCT EFFECT VARIABLE 5 0.0013
170 ASEPTIC NECROSIS BONE 1 0.0013
171 THYROID HORMONES DECREASED 1 0.0013
172 ERYTHRODERMIC PSORIASIS 1 0.0012
173 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
174 FOETAL DISORDER 1 0.0012
175 ADRENAL SUPPRESSION 1 0.0012
176 DYSLIPIDAEMIA 6 0.0012
177 HEPATIC HAEMORRHAGE 1 0.0012
178 ADENOMA BENIGN 1 0.0012
179 HYPERAMMONAEMIC ENCEPHALOPATHY 2 0.0011
180 AUTOIMMUNE HEPATITIS 8 0.0011
181 BRAIN FOG 18 0.0011
182 FOOD REFUSAL 1 0.0011
183 GAMMA-GLUTAMYLTRANSFERASE INCREASED 25 0.0011
184 DRUG LEVEL FLUCTUATING 1 0.0011
185 BLOOD POTASSIUM ABNORMAL 3 0.0011
186 CARDIOTOXICITY 10 0.0011
187 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
188 NEUROPSYCHIATRIC SYMPTOMS 1 0.0011
189 HYPOTHYROIDISM 35 0.0011
190 METASTASES TO ADRENALS 1 0.0011
191 ENTEROCOLITIS INFECTIOUS 1 0.0011
192 PREMATURE MENOPAUSE 1 0.0011
193 PROTHROMBIN LEVEL DECREASED 1 0.0011
194 CEREBRAL THROMBOSIS 3 0.0011
195 EXPOSURE VIA DIRECT CONTACT 1 0.0011
196 KLEBSIELLA BACTERAEMIA 1 0.0011
197 PRODUCT AFTER TASTE 1 0.0010
198 PCO2 DECREASED 1 0.0010
199 ONCOLOGIC COMPLICATION 1 0.0010
200 IMMUNE-MEDIATED HEPATIC DISORDER 2 0.0010
201 BICYTOPENIA 2 0.0010
202 HAEMANGIOMA OF LIVER 1 0.0010
203 METASTASIS 7 0.0010
204 HYPERPARATHYROIDISM 2 0.0010
205 METASTASES TO SKIN 1 0.0010
206 LIVEDO RETICULARIS 2 0.0010
207 WALKING DISABILITY 2 0.0010
208 COGWHEEL RIGIDITY 1 0.0010
209 OEDEMA MUCOSAL 1 0.0010
210 BLOOD TESTOSTERONE INCREASED 2 0.0009
211 ATAXIA 11 0.0009
212 CEREBELLAR SYNDROME 2 0.0009
213 DEAFNESS NEUROSENSORY 3 0.0009
214 CHOLESTATIC LIVER INJURY 2 0.0009
215 ADENOCARCINOMA 2 0.0009
216 TONGUE ULCERATION 3 0.0009
217 SUBCLAVIAN VEIN THROMBOSIS 1 0.0009
218 CORTISOL DECREASED 1 0.0009
219 PO2 DECREASED 1 0.0009
220 SHOCK HAEMORRHAGIC 7 0.0009
221 ESCHERICHIA BACTERAEMIA 2 0.0008
222 BONE MARROW TOXICITY 1 0.0008
223 DEVICE RELATED INFECTION 13 0.0008
224 ELECTROCARDIOGRAM QT PROLONGED 30 0.0008
225 EMBOLISM ARTERIAL 1 0.0008
226 IMMUNE-MEDIATED ENTEROCOLITIS 3 0.0008
227 CARDIOMYOPATHY 12 0.0008
228 PIGMENTATION DISORDER 5 0.0008
229 BLOOD UREA DECREASED 1 0.0008
230 RENAL ATROPHY 1 0.0008
231 GASTROINTESTINAL TUBE INSERTION 2 0.0008
232 MALIGNANT NEOPLASM PROGRESSION 82 0.0008
233 OVARIAN CYST 8 0.0008
234 NEUROTOXICITY 14 0.0008
235 ABORTION MISSED 1 0.0008
236 DRUG LEVEL DECREASED 8 0.0008
237 FEBRILE NEUTROPENIA 52 0.0008
238 SEDATION COMPLICATION 2 0.0008
239 BLOOD BILIRUBIN ABNORMAL 1 0.0008
240 HYPONATRAEMIA 44 0.0008
241 OBSTRUCTION GASTRIC 1 0.0008
242 HEPATOCELLULAR INJURY 11 0.0008
243 HEPATITIS TOXIC 2 0.0008
244 ACQUIRED GENE MUTATION 1 0.0008
245 PSYCHOMOTOR SKILLS IMPAIRED 2 0.0008
246 HEAD TITUBATION 1 0.0007
247 ACCIDENTAL EXPOSURE 3 0.0007
248 LUNG CONSOLIDATION 2 0.0007
249 PERIPHERAL MOTOR NEUROPATHY 1 0.0007
250 INTESTINAL FISTULA 1 0.0007
251 TRACHEOSTOMY 1 0.0007
252 NEUROLOGICAL SYMPTOM 4 0.0007
253 ANOREXIA 9 0.0007
254 PELVIC VENOUS THROMBOSIS 1 0.0007
255 PORPHYRIA ACUTE 1 0.0007
256 GASTROINTESTINAL NECROSIS 2 0.0007
257 PANCREATIC ENZYMES INCREASED 1 0.0007
258 NORMOCYTIC ANAEMIA 1 0.0007
259 DARK CIRCLES UNDER EYES 1 0.0007
260 GENERALISED ANXIETY DISORDER 1 0.0007
261 BACTERAEMIA 8 0.0007
262 HYPERTHERMIA MALIGNANT 1 0.0007
263 PITUITARY TUMOUR 1 0.0007
264 MENTAL FATIGUE 1 0.0007
265 METABOLIC ENCEPHALOPATHY 2 0.0007
266 DISEASE PROGRESSION 78 0.0007
267 HYPERTHERMIA 5 0.0007
268 IMMUNE-MEDIATED ADVERSE REACTION 1 0.0007
269 BACTERIAL VAGINOSIS 1 0.0006
270 HEPATITIS ACUTE 4 0.0006
271 ENTEROBACTER INFECTION 1 0.0006
272 DEAFNESS BILATERAL 1 0.0006
273 HYPOCALCAEMIA 11 0.0006
274 MYCOBACTERIAL INFECTION 1 0.0006
275 ACUTE SINUSITIS 1 0.0006
276 BLOOD CREATININE ABNORMAL 2 0.0006
277 FOOD INTERACTION 1 0.0006
278 OBSESSIVE THOUGHTS 1 0.0006
279 IMMUNE-MEDIATED LUNG DISEASE 1 0.0005
280 VENTRICULAR ARRHYTHMIA 2 0.0005
281 IRON DEFICIENCY ANAEMIA 5 0.0005
282 OPPORTUNISTIC INFECTION 1 0.0005
283 FEELING DRUNK 4 0.0005
284 PULMONARY MASS 8 0.0005
285 HYPOPROTEINAEMIA 1 0.0005
286 OSTEOPOROTIC FRACTURE 1 0.0005
287 HYPOREFLEXIA 1 0.0005
288 ADRENAL DISORDER 1 0.0005
289 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
290 METASTASES TO LIVER 9 0.0005
291 EPIGASTRIC DISCOMFORT 2 0.0005
292 PSYCHIATRIC DECOMPENSATION 1 0.0005
293 DECREASED APPETITE 117 0.0005
294 POLYNEUROPATHY 6 0.0005
295 HYPOKALAEMIA 23 0.0005
296 MUCOSAL DRYNESS 1 0.0005
297 LIPIDS INCREASED 1 0.0005
298 VAGINAL DISCHARGE 5 0.0005
299 HEPATOTOXICITY 11 0.0005
300 HICCUPS 4 0.0005
301 CHOLANGITIS SCLEROSING 1 0.0005
302 NEUTROPENIA 66 0.0005
303 GYNAECOMASTIA 15 0.0005
304 PRODUCT DOSE OMISSION ISSUE 142 0.0005
305 DISTURBANCE IN ATTENTION 26 0.0005
306 BODY TEMPERATURE FLUCTUATION 1 0.0005
307 GASTROENTERITIS 7 0.0005
308 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
309 OPTIC NEUROPATHY 1 0.0005
310 DRUG INTERACTION 74 0.0005
311 INFUSION SITE BRUISING 1 0.0005
312 HORDEOLUM 2 0.0005
313 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
314 MUCOSAL INFLAMMATION 12 0.0005
315 DYSPHEMIA 2 0.0005
316 HAEMORRHAGIC ANAEMIA 2 0.0005
317 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
318 METASTASES TO MENINGES 1 0.0004
319 READING DISORDER 1 0.0004
320 DENGUE FEVER 1 0.0004
321 RETINAL DETACHMENT 4 0.0004
322 HAEMANGIOMA 1 0.0004
323 LICHEN PLANUS 1 0.0004
324 ELECTROLYTE IMBALANCE 5 0.0004
325 INFUSION SITE INFECTION 1 0.0004
326 HYPERKALAEMIA 15 0.0004
327 HEPATIC ENZYME INCREASED 29 0.0004
328 DYSMORPHISM 1 0.0004
329 DISTURBANCE IN SOCIAL BEHAVIOUR 1 0.0004
330 INTENTIONAL DOSE OMISSION 12 0.0004
331 NEUTROPENIC SEPSIS 3 0.0004
332 LONG QT SYNDROME 1 0.0004
333 CHOLESTASIS 8 0.0004
334 MAJOR DEPRESSION 3 0.0004
335 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
336 HYPERVOLAEMIA 2 0.0004
337 NAUSEA 319 0.0004
338 NEOPLASM PROGRESSION 14 0.0004
339 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 22 0.0004
340 DERMATITIS EXFOLIATIVE 2 0.0004
341 HEPATIC CYTOLYSIS 5 0.0004
342 PETIT MAL EPILEPSY 2 0.0004
343 ABDOMINAL INFECTION 1 0.0004
344 INCREASED BRONCHIAL SECRETION 1 0.0004
345 MEAN CELL VOLUME INCREASED 1 0.0004
346 MEDICATION RESIDUE 1 0.0004
347 PERSONALITY DISORDER 1 0.0004
348 VERTIGO 23 0.0004
349 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
350 FATIGUE 291 0.0004
351 EAR CONGESTION 1 0.0004
352 NORMAL NEWBORN 2 0.0004
353 CLONUS 1 0.0004
354 PERIPHERAL COLDNESS 5 0.0004
355 INTESTINAL ISCHAEMIA 2 0.0004
356 EMBOLISM 3 0.0004
357 RASH MORBILLIFORM 1 0.0004
358 EOSINOPHIL COUNT INCREASED 3 0.0004
359 TRICHORRHEXIS 1 0.0004
360 ELECTRIC SHOCK SENSATION 1 0.0004
361 ENDOTRACHEAL INTUBATION 1 0.0004
362 LYMPHOPENIA 5 0.0004
363 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
364 OFF LABEL USE 307 0.0004
365 SKIN HYPERPIGMENTATION 3 0.0003
366 BALANCE DISORDER 30 0.0003
367 SEPTIC SHOCK 15 0.0003
368 STRABISMUS 1 0.0003
369 ANAEMIA 64 0.0003
370 HYPERLIPIDAEMIA 4 0.0003
371 VOMITING 157 0.0003
372 HEPATITIS CHOLESTATIC 2 0.0003
373 BLOOD COUNT ABNORMAL 5 0.0003
374 SCHIZOPHRENIA 4 0.0003
375 DYSAESTHESIA 1 0.0003
376 ECTOPIC PREGNANCY 1 0.0003
377 GASTROINTESTINAL DISORDER 29 0.0003
378 MULTIPLE-DRUG RESISTANCE 1 0.0003
379 PANCYTOPENIA 18 0.0003
380 FLANK PAIN 3 0.0003
381 BLOOD BLISTER 1 0.0003
382 ABORTION INDUCED 3 0.0003
383 INFUSION SITE PRURITUS 1 0.0003
384 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
385 NEUROPATHY PERIPHERAL 30 0.0003
386 POLYMYALGIA RHEUMATICA 1 0.0003
387 MULTIPLE DRUG OVERDOSE INTENTIONAL 1 0.0003
388 PRESCRIBED OVERDOSE 6 0.0003
389 TENDON DISORDER 2 0.0003
390 BRADYPHRENIA 2 0.0003
391 OEDEMA MOUTH 1 0.0003
392 BREAST ENLARGEMENT 1 0.0003
393 THROMBOSIS IN DEVICE 1 0.0003
394 ORAL CANDIDIASIS 4 0.0003
395 DYSGRAPHIA 2 0.0003
396 DRUG LEVEL INCREASED 5 0.0003
397 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
398 THERAPEUTIC AGENT TOXICITY 1 0.0003
399 COGNITIVE DISORDER 14 0.0003
400 METASTASES TO SPINE 1 0.0003
401 TASTE DISORDER 6 0.0003
402 NEOPLASM RECURRENCE 1 0.0003
403 EPILEPSY 9 0.0003
404 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
405 SLUGGISHNESS 3 0.0003
406 APLASIA PURE RED CELL 1 0.0003
407 HAIR GROWTH ABNORMAL 2 0.0003
408 AMENORRHOEA 5 0.0003
409 ENCEPHALOPATHY 7 0.0003
410 SUDDEN DEATH 3 0.0003
411 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
412 BREAST PAIN 3 0.0003
413 ASTHENIA 105 0.0003
414 PYODERMA GANGRENOSUM 1 0.0003
415 DISORIENTATION 11 0.0003
416 FOOD INTOLERANCE 1 0.0003
417 ADVERSE EVENT 25 0.0003
418 TRANSAMINASES INCREASED 6 0.0003
419 RASH MACULO-PAPULAR 6 0.0003
420 DYSGEUSIA 20 0.0003
421 SEPSIS 30 0.0003
422 THROMBOCYTOPENIA 30 0.0003
423 DIARRHOEA 173 0.0003
424 INTESTINAL PERFORATION 3 0.0003
425 AUTOIMMUNE THYROIDITIS 1 0.0003
426 PARANASAL SINUS DISCOMFORT 1 0.0003
427 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
428 SHOCK 6 0.0003
429 SOMNOLENCE 52 0.0003
430 PANIC DISORDER 1 0.0003
431 ORAL INFECTION 1 0.0003
432 MEMORY IMPAIRMENT 35 0.0003
433 RESPIRATORY DISTRESS 7 0.0003
434 STOMATITIS 15 0.0002
435 RECURRENT CANCER 1 0.0002
436 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
437 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
438 DIZZINESS 120 0.0002
439 MUSCLE FATIGUE 1 0.0002
440 HEPATITIS 6 0.0002
441 BLOOD POTASSIUM DECREASED 7 0.0002
442 ABDOMINAL DISCOMFORT 39 0.0002
443 DEHYDRATION 31 0.0002
444 HEPATIC FAILURE 7 0.0002
445 METASTATIC NEOPLASM 1 0.0002
446 HEPATIC LESION 1 0.0002
447 PYELONEPHRITIS 2 0.0002
448 TOOTH INJURY 1 0.0002
449 MELANOCYTIC NAEVUS 1 0.0002
450 IMMUNOSUPPRESSION 2 0.0002
451 PHYSICAL DISABILITY 1 0.0002
452 WEIGHT DECREASED 63 0.0002
453 LOSS OF LIBIDO 2 0.0002
454 IRON DEFICIENCY 1 0.0002
455 PAPILLOEDEMA 1 0.0002
456 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
457 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
458 PERFORMANCE STATUS DECREASED 1 0.0002
459 PREGNANCY WITH IMPLANT CONTRACEPTIVE 1 0.0002
460 SLEEP DISORDER 15 0.0002
461 BLOOD SODIUM DECREASED 4 0.0002
462 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
463 PULSE ABSENT 1 0.0002
464 AFFECT LABILITY 2 0.0002
465 ENTEROCOCCAL INFECTION 1 0.0002
466 MENTAL IMPAIRMENT 5 0.0002
467 APATHY 3 0.0002
468 HORMONE LEVEL ABNORMAL 1 0.0002
469 EXPIRED DRUG ADMINISTERED 1 0.0002
470 ORGANISING PNEUMONIA 1 0.0002
471 INFLAMMATORY MARKER INCREASED 1 0.0002
472 ABDOMINAL TENDERNESS 1 0.0002
473 HYPERNATRAEMIA 1 0.0002
474 THERAPY NON-RESPONDER 9 0.0002
475 SYNCOPE 20 0.0002
476 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
477 HYPOXIA 7 0.0002
478 APHASIA 6 0.0002
479 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
480 FEEDING DISORDER 4 0.0002
481 PATHOLOGICAL FRACTURE 1 0.0002
482 BONE MARROW FAILURE 4 0.0002
483 CACHEXIA 1 0.0002
484 EJECTION FRACTION DECREASED 3 0.0002
485 FAILURE TO THRIVE 1 0.0002
486 DEAFNESS 5 0.0002
487 MOUTH ULCERATION 4 0.0002
488 BLOOD LACTIC ACID INCREASED 1 0.0002
489 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
490 FOOD POISONING 1 0.0002
491 RECTAL HAEMORRHAGE 8 0.0002
492 STRESS FRACTURE 1 0.0002
493 FREQUENT BOWEL MOVEMENTS 5 0.0002
494 MUSCULAR WEAKNESS 21 0.0002
495 BLOOD POTASSIUM INCREASED 3 0.0002
496 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
497 FAECALOMA 1 0.0002
498 GASTROINTESTINAL PAIN 2 0.0002
499 GENERAL PHYSICAL HEALTH DETERIORATION 21 0.0002
500 CHOKING SENSATION 1 0.0002
501 DIVERTICULITIS 5 0.0002
502 LEUKOPENIA 9 0.0002
503 STREPTOCOCCAL INFECTION 1 0.0002
504 PULMONARY EMBOLISM 17 0.0002
505 MACULAR OEDEMA 1 0.0002
506 PANCREATITIS ACUTE 4 0.0002
507 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
508 CHOLECYSTITIS ACUTE 1 0.0002
509 HYPERTONIA 1 0.0002
510 CONSTIPATION 38 0.0002
511 LETHARGY 10 0.0002
512 GASTRIC HAEMORRHAGE 2 0.0002
513 EXERCISE TOLERANCE DECREASED 1 0.0002
514 MOUTH SWELLING 1 0.0002
515 RENAL FAILURE 23 0.0002
516 METABOLIC DISORDER 1 0.0002
517 STRESS CARDIOMYOPATHY 1 0.0002
518 LIVER FUNCTION TEST ABNORMAL 5 0.0002
519 CAESAREAN SECTION 2 0.0002
520 SPEECH DISORDER 9 0.0002
521 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
522 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
523 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
524 BRADYKINESIA 1 0.0002
525 COVID-19 PNEUMONIA 2 0.0002
526 HOSPITALISATION 26 0.0002
527 AMNESIA 11 0.0002
528 SINUS HEADACHE 1 0.0002
529 MYOCLONUS 2 0.0002
530 ODYNOPHAGIA 1 0.0002
531 PELVIC PAIN 3 0.0002
532 ABASIA 4 0.0002
533 OLIGURIA 1 0.0002
534 CONFUSIONAL STATE 26 0.0002
535 AGEUSIA 4 0.0002
536 SECRETION DISCHARGE 2 0.0002
537 PHOTOPSIA 1 0.0002
538 MOOD SWINGS 5 0.0002
539 METABOLIC ACIDOSIS 5 0.0002
540 ROTATOR CUFF SYNDROME 2 0.0002
541 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
542 DIPLOPIA 4 0.0002
543 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
544 ABNORMAL BEHAVIOUR 6 0.0002
545 CORONAVIRUS INFECTION 1 0.0002
546 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
547 BLOOD CHOLESTEROL INCREASED 7 0.0002
548 MENSTRUATION IRREGULAR 4 0.0001
549 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
550 BRONCHIECTASIS 1 0.0001
551 PRODUCT TASTE ABNORMAL 2 0.0001
552 OEDEMA 8 0.0001
553 COMA 7 0.0001
554 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
555 BLOOD TESTOSTERONE DECREASED 1 0.0001
556 INFARCTION 1 0.0001
557 EYE MOVEMENT DISORDER 1 0.0001
558 CARDIAC ARREST 12 0.0001
559 DROOLING 1 0.0001
560 LYMPHOEDEMA 1 0.0001
561 FORMICATION 1 0.0001
562 RIGHT VENTRICULAR FAILURE 1 0.0001
563 PAPULE 1 0.0001
564 DUODENAL ULCER 1 0.0001
565 RETCHING 3 0.0001
566 PARAESTHESIA 22 0.0001
567 LIVER FUNCTION TEST INCREASED 3 0.0001
568 PRODUCT PRESCRIBING ISSUE 3 0.0001
569 FLUID OVERLOAD 2 0.0001
570 INTENTIONAL UNDERDOSE 1 0.0001
571 ORAL DISORDER 1 0.0001
572 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
573 PSYCHIATRIC SYMPTOM 1 0.0001
574 HYPOPHOSPHATAEMIA 1 0.0001
575 PRODUCT USE IN UNAPPROVED INDICATION 33 0.0001
576 DYSARTHRIA 5 0.0001
577 PAROSMIA 1 0.0001
578 HAEMODYNAMIC INSTABILITY 1 0.0001
579 VISION BLURRED 18 0.0001
580 ACIDOSIS 1 0.0001
581 BOWEL MOVEMENT IRREGULARITY 1 0.0001
582 PROCEDURAL COMPLICATION 1 0.0001
583 DRUG ADMINISTRATION ERROR 4 0.0001
584 PYREXIA 45 0.0001
585 EMOTIONAL DISORDER 4 0.0001
586 WHITE BLOOD CELL COUNT DECREASED 14 0.0001
587 ABDOMINAL PAIN 30 0.0001
588 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
589 MULTIPLE ALLERGIES 1 0.0001
590 DRUG-INDUCED LIVER INJURY 4 0.0001
591 ALOPECIA 25 0.0001
592 AFFECTIVE DISORDER 1 0.0001
593 DYSPHAGIA 12 0.0001
594 BLOOD ALBUMIN DECREASED 1 0.0001
595 GAIT DISTURBANCE 24 0.0001
596 ABSCESS 2 0.0001
597 BLOOD DISORDER 1 0.0001
598 THROMBOSIS 10 0.0001
599 DRUG INTOLERANCE 12 0.0001
600 SENSORY LOSS 1 0.0001
601 DEPRESSION 28 0.0001
602 ASPHYXIA 1 0.0001
603 ABNORMAL FAECES 1 0.0001
604 METASTASES TO BONE 2 0.0001
605 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
606 EPISTAXIS 9 0.0001
607 SURGERY 7 0.0001
608 SENSATION OF FOREIGN BODY 1 0.0001
609 ANGER 4 0.0001
610 CARDIOVASCULAR DISORDER 3 0.0001
611 RENAL FAILURE ACUTE 5 0.0001
612 METRORRHAGIA 2 0.0001
613 ILLNESS 12 0.0001
614 RASH GENERALISED 3 0.0001
615 MYOPATHY 1 0.0001
616 MULTI-ORGAN FAILURE 2 0.0001
617 DELIRIUM 4 0.0001
618 PLEURAL EFFUSION 7 0.0001
619 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
620 GROIN PAIN 1 0.0001
621 GRIP STRENGTH DECREASED 1 0.0001
622 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
623 LYMPHOCYTE COUNT DECREASED 2 0.0001
624 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
625 PURPURA 1 0.0001
626 DRUG ERUPTION 2 0.0001
627 ABDOMINAL PAIN UPPER 23 0.0001
628 HAEMOLYTIC ANAEMIA 1 0.0001
629 GASTROINTESTINAL INFECTION 1 0.0001
630 JAUNDICE 3 0.0001
631 ANAL INCONTINENCE 1 0.0001
632 HEAVY MENSTRUAL BLEEDING 1 0.0001
633 CHILLS 13 0.0001
634 DEVELOPMENTAL DELAY 1 0.0001
635 OROPHARYNGEAL DISCOMFORT 1 0.0001
636 LUPUS-LIKE SYNDROME 1 0.0001
637 PNEUMONITIS 3 0.0001
638 OPTIC NEURITIS 1 0.0001
639 C-REACTIVE PROTEIN INCREASED 4 0.0001
640 HYPOTENSION 22 0.0001
641 RESTLESSNESS 4 0.0001
642 PNEUMONIA BACTERIAL 1 0.0001
643 BRAIN NEOPLASM 1 0.0001
644 TINNITUS 5 0.0001
645 GRAND MAL CONVULSION 1 0.0001
646 MENTAL STATUS CHANGES 3 0.0001
647 AGRANULOCYTOSIS 2 0.0001
648 HAEMOPTYSIS 3 0.0001
649 DEMENTIA 3 0.0001
650 ERYTHEMA MULTIFORME 1 0.0001
651 BACTERIAL INFECTION 2 0.0001
652 HEPATIC ENCEPHALOPATHY 1 0.0001
653 RENAL IMPAIRMENT 9 0.0001
654 HOT FLUSH 8 0.0001
655 RASH 46 0.0001
656 PRODUCT PACKAGING ISSUE 1 0.0001
657 PROTEINURIA 2 0.0001
658 PNEUMONIA 34 0.0001
659 DIABETES MELLITUS 8 0.0001
660 RED BLOOD CELL COUNT DECREASED 3 0.0001
661 NEOPLASM MALIGNANT 7 0.0001
662 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
663 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 21 0.0001
664 THROMBOTIC MICROANGIOPATHY 1 0.0001
665 BONE PAIN 6 0.0001
666 PHARYNGEAL SWELLING 1 0.0001
667 DEATH 88 0.0001
668 OVERDOSE 22 0.0001
669 MENORRHAGIA 2 0.0001
670 HEPATOMEGALY 1 0.0001
671 THERAPY CHANGE 1 0.0001
672 BODY TEMPERATURE DECREASED 1 0.0001
673 PSYCHOTIC DISORDER 3 0.0001
674 HAEMATOCRIT DECREASED 2 0.0001
675 BLOOD PRESSURE ABNORMAL 2 0.0001
676 DRUG INEFFECTIVE 132 0.0001
677 SALIVARY HYPERSECRETION 1 0.0001
678 SPINAL FRACTURE 2 0.0001
679 CARDIAC FAILURE 8 0.0001
680 TOXIC SKIN ERUPTION 1 0.0001
681 THERAPEUTIC RESPONSE DECREASED 6 0.0001
682 NEUTROPHIL COUNT INCREASED 1 0.0001
683 EUPHORIC MOOD 1 0.0001
684 HYPERBILIRUBINAEMIA 1 0.0001
685 TREMOR 16 0.0001
686 NERVOUS SYSTEM DISORDER 3 0.0001
687 RESPIRATORY FAILURE 7 0.0001
688 ABDOMINAL DISTENSION 10 0.0001
689 FULL BLOOD COUNT ABNORMAL 1 0.0001
690 RENAL PAIN 1 0.0001
691 EATING DISORDER 2 0.0001
692 INTENTIONAL OVERDOSE 6 0.0001
693 NIGHT SWEATS 3 0.0001
694 POOR QUALITY SLEEP 2 0.0001
695 ATRIAL FIBRILLATION 9 0.0001
696 RASH PRURITIC 5 0.0001
697 PULMONARY THROMBOSIS 1 0.0001
698 OESOPHAGITIS 1 0.0001
699 ACUTE KIDNEY INJURY 14 0.0001
700 CHOLELITHIASIS 3 0.0001
701 HEADACHE 57 0.0001
702 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
703 LIVER DISORDER 4 0.0001
704 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
705 HYPERTENSIVE CRISIS 1 0.0001
706 SNEEZING 2 0.0001
707 SKIN INFECTION 1 0.0001
708 NEPHROPATHY TOXIC 1 0.0001
709 BLOOD CALCIUM DECREASED 1 0.0001
710 IMPAIRED DRIVING ABILITY 1 0.0001
711 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
712 GASTRIC DISORDER 3 0.0001
713 MYOCARDITIS 1 0.0001
714 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
715 POST PROCEDURAL HAEMORRHAGE 1 0.0001
716 RASH MACULAR 3 0.0001
717 THERAPY INTERRUPTED 6 0.0001
718 INTERSTITIAL LUNG DISEASE 4 0.0001
719 HYPOGLYCAEMIA 4 0.0001
720 MYALGIA 14 0.0001
721 HYPERGLYCAEMIA 3 0.0001
722 NEURALGIA 2 0.0001
723 OEDEMA PERIPHERAL 10 0.0001
724 CYTOPENIA 1 0.0001
725 FEELING HOT 5 0.0001
726 LIVER INJURY 2 0.0001
727 DYSPEPSIA 8 0.0001
728 HYPERCALCAEMIA 1 0.0001
729 PHARYNGITIS 1 0.0001
730 TOOTH EXTRACTION 1 0.0001
731 AGGRESSION 4 0.0001
732 PRODUCT USE ISSUE 15 0.0001
733 POISONING 1 0.0001
734 DERMATITIS ALLERGIC 1 0.0001
735 COLITIS 3 0.0001
736 MUSCLE ATROPHY 1 0.0001
737 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
738 HYPOPHAGIA 2 0.0001
739 MYDRIASIS 1 0.0001
740 THERAPY CESSATION 4 0.0001
741 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
742 INFUSION SITE PAIN 1 0.0001
743 PLASMA CELL MYELOMA 3 0.0001
744 NODULE 1 0.0001
745 GASTRITIS 2 0.0001
746 PANCREATITIS 4 0.0001
747 BLOOD PRESSURE DECREASED 5 0.0001
748 MALAISE 33 0.0001
749 QUALITY OF LIFE DECREASED 1 0.0001
750 FEAR 2 0.0001
751 IMPAIRED GASTRIC EMPTYING 1 0.0001
752 MOOD ALTERED 2 0.0001
753 GINGIVAL BLEEDING 1 0.0001
754 ACUTE HEPATIC FAILURE 1 0.0001
755 OSTEOPOROSIS 3 0.0001
756 SKIN LESION 2 0.0001
757 ABNORMAL DREAMS 2 0.0001
758 ORAL DISCOMFORT 1 0.0001
759 HYPOMAGNESAEMIA 1 0.0001
760 COORDINATION ABNORMAL 1 0.0001
761 APHONIA 1 0.0001
762 BLOOD TEST ABNORMAL 1 0.0001
763 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
764 SKIN REACTION 1 0.0001
765 HYPERTENSION 15 0.0001
766 SEASONAL ALLERGY 1 0.0001
767 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
768 SINUS TACHYCARDIA 1 0.0001
769 SUBDURAL HAEMATOMA 1 0.0001
770 HYPERSOMNIA 2 0.0001
771 CARDIOGENIC SHOCK 1 0.0001
772 PARAESTHESIA ORAL 1 0.0001
773 VAGINAL HAEMORRHAGE 3 0.0001
774 INFECTION 10 0.0001
775 HYPERTHYROIDISM 1 0.0001
776 HYPOKINESIA 1 0.0001
777 ASCITES 2 0.0001
778 TACHYCARDIA 6 0.0001
779 RESPIRATORY DISORDER 2 0.0001
780 HALLUCINATION 5 0.0001
781 SUICIDE ATTEMPT 4 0.0001
782 OSTEOPENIA 1 0.0001
783 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
784 PLATELET COUNT DECREASED 7 0.0001
785 DISCOMFORT 4 0.0001
786 THYROID DISORDER 1 0.0001
787 MUSCULOSKELETAL CHEST PAIN 1 0.0001
788 ANKLE FRACTURE 1 0.0001
789 DELUSION 1 0.0001
790 LUNG INFECTION 1 0.0001
791 EXPOSURE DURING PREGNANCY 4 0.0001
792 THERAPY PARTIAL RESPONDER 1 0.0001
793 SWOLLEN TONGUE 2 0.0001
794 CYSTITIS 2 0.0001
795 BLOOD GLUCOSE DECREASED 3 0.0001
796 SENSORY DISTURBANCE 1 0.0001
797 IMPAIRED HEALING 2 0.0001
798 VISUAL ACUITY REDUCED 2 0.0001
799 HYPOAESTHESIA 9 0.0001
800 COAGULOPATHY 1 0.0001
801 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
802 HEMIPARESIS 1 0.0001
803 URINARY TRACT INFECTION 10 0.0001
804 PARANOIA 1 0.0001
805 ORTHOSTATIC HYPOTENSION 1 0.0001
806 LOCAL SWELLING 1 0.0001
807 PRURITUS 22 0.0001
808 DEPRESSED MOOD 3 0.0001
809 COLD SWEAT 1 0.0001
810 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
811 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
812 THIRST 1 0.0001
813 CONDITION AGGRAVATED 17 0.0001
814 MYELOSUPPRESSION 2 0.0001
815 TOOTHACHE 1 0.0001
816 OSTEOMYELITIS 1 0.0001
817 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
818 ACCIDENTAL OVERDOSE 2 0.0001
819 LOSS OF CONSCIOUSNESS 7 0.0001
820 OROPHARYNGEAL PAIN 5 0.0001
821 THINKING ABNORMAL 1 0.0001
822 HEPATIC FUNCTION ABNORMAL 2 0.0001
823 SWELLING 5 0.0001
824 OXYGEN SATURATION DECREASED 3 0.0001
825 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
826 HEPATIC CIRRHOSIS 1 0.0001
827 PHOTOPHOBIA 1 0.0001
828 DYSPNOEA 30 0.0001
829 SLEEP APNOEA SYNDROME 1 0.0001
830 POST PROCEDURAL COMPLICATION 1 0.0001
831 DRUG PRESCRIBING ERROR 1 0.0001
832 ACUTE RESPIRATORY FAILURE 1 0.0001
833 CONTUSION 5 0.0001
834 EAR PAIN 1 0.0001
835 COVID-19 9 0.0001
836 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
837 HAEMORRHOIDS 1 0.0001
838 ORAL HERPES 1 0.0001
839 KIDNEY INFECTION 1 0.0001
840 DISABILITY 1 0.0001
841 SINUS DISORDER 1 0.0001
842 PRESCRIBED UNDERDOSE 1 0.0001
843 FEELING ABNORMAL 12 0.0001
844 PRODUCT PHYSICAL ISSUE 1 0.0000
845 DYSKINESIA 2 0.0000
846 NEUTROPHIL COUNT DECREASED 2 0.0000
847 MUSCLE SPASMS 9 0.0000
848 LUNG NEOPLASM MALIGNANT 2 0.0000
849 RIB FRACTURE 1 0.0000
850 CHEST PAIN 9 0.0000
851 INTENTIONAL DRUG MISUSE 1 0.0000
852 HAEMORRHAGE 5 0.0000
853 DERMATITIS 1 0.0000
854 WITHDRAWAL SYNDROME 2 0.0000
855 HALLUCINATION, VISUAL 1 0.0000
856 JOINT INJURY 1 0.0000
857 HYPERHIDROSIS 6 0.0000
858 RHINORRHOEA 3 0.0000
859 PRURITUS GENERALISED 1 0.0000
860 MENTAL DISORDER 2 0.0000
861 BLOOD CREATININE INCREASED 3 0.0000
862 BLOOD PRESSURE INCREASED 7 0.0000
863 PERIPHERAL SWELLING 7 0.0000
864 INSOMNIA 12 0.0000
865 STEVENS-JOHNSON SYNDROME 1 0.0000
866 TOOTH DISORDER 1 0.0000
867 COLITIS ULCERATIVE 2 0.0000
868 GLOSSODYNIA 1 0.0000
869 PULMONARY OEDEMA 2 0.0000
870 ORAL PAIN 1 0.0000
871 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
872 CHROMATURIA 1 0.0000
873 HEART RATE IRREGULAR 1 0.0000
874 PRODUCT AVAILABILITY ISSUE 1 0.0000
875 SEIZURE 5 0.0000
876 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
877 PERICARDIAL EFFUSION 1 0.0000
878 BURNING SENSATION 3 0.0000
879 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
880 ANXIETY 12 0.0000
881 OCULAR HYPERAEMIA 2 0.0000
882 PRODUCT PRESCRIBING ERROR 1 0.0000
883 MIGRAINE 4 0.0000
884 BLOOD PRESSURE FLUCTUATION 1 0.0000
885 ARTHRALGIA 17 0.0000
886 AGITATION 3 0.0000
887 LUNG DISORDER 2 0.0000
888 HEART RATE INCREASED 4 0.0000
889 EXTRAPYRAMIDAL DISORDER 1 0.0000
890 CELLULITIS 2 0.0000
891 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
892 ABDOMINAL PAIN LOWER 1 0.0000
893 FLUID RETENTION 2 0.0000
894 DRUG RESISTANCE 1 0.0000
895 BACK PAIN 9 0.0000
896 HAEMATOMA 1 0.0000
897 MUSCULOSKELETAL PAIN 2 0.0000
898 JOINT STIFFNESS 1 0.0000
899 NASOPHARYNGITIS 7 0.0000
900 EAR INFECTION 1 0.0000
901 BLOOD BILIRUBIN INCREASED 1 0.0000
902 THROAT TIGHTNESS 1 0.0000
903 RESPIRATORY ARREST 1 0.0000
904 TREATMENT FAILURE 3 0.0000
905 MEDICATION ERROR 2 0.0000
906 FEELING COLD 1 0.0000
907 TOXICITY TO VARIOUS AGENTS 6 0.0000
908 PAIN IN JAW 1 0.0000
909 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
910 CONVULSION 2 0.0000
911 DYSPHONIA 2 0.0000
912 PALPITATIONS 4 0.0000
913 LABORATORY TEST ABNORMAL 1 0.0000
914 LACRIMATION INCREASED 1 0.0000
915 SUICIDAL IDEATION 3 0.0000
916 SWELLING FACE 2 0.0000
917 PAIN IN EXTREMITY 9 0.0000
918 OSTEONECROSIS 1 0.0000
919 FALL 10 0.0000
920 FUNGAL INFECTION 1 0.0000
921 GAIT INABILITY 1 0.0000
922 EYE PRURITUS 1 0.0000
923 PAIN 18 0.0000
924 SINUSITIS 3 0.0000
925 HAEMATURIA 1 0.0000
926 DRUG EFFECT INCOMPLETE 1 0.0000
927 CRYING 1 0.0000
928 DYSURIA 1 0.0000
929 INFLUENZA 3 0.0000
930 WEIGHT INCREASED 6 0.0000
931 DYSPNOEA EXERTIONAL 1 0.0000
932 INTESTINAL OBSTRUCTION 1 0.0000
933 COUGH 7 0.0000
934 ABORTION SPONTANEOUS 1 0.0000
935 CARDIAC FAILURE CONGESTIVE 2 0.0000
936 PROSTATE CANCER 2 0.0000
937 DRY MOUTH 2 0.0000
938 BLINDNESS 1 0.0000
939 INFLUENZA LIKE ILLNESS 2 0.0000
940 VISUAL IMPAIRMENT 3 0.0000
941 COMPLETED SUICIDE 2 0.0000
942 RHABDOMYOLYSIS 1 0.0000
943 POLLAKIURIA 1 0.0000
944 CARDIO-RESPIRATORY ARREST 1 0.0000
945 ROAD TRAFFIC ACCIDENT 1 0.0000
946 URTICARIA 4 0.0000
947 SKIN EXFOLIATION 2 0.0000
948 HYPOACUSIS 1 0.0000
949 ANGIOEDEMA 1 0.0000
950 DRY SKIN 3 0.0000
951 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
952 ADVERSE DRUG REACTION 2 0.0000
953 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
954 PRODUCT QUALITY ISSUE 3 0.0000
955 SKIN IRRITATION 1 0.0000
956 RENAL DISORDER 1 0.0000
957 ARRHYTHMIA 1 0.0000
958 DISEASE RECURRENCE 1 0.0000
959 PRODUCTIVE COUGH 1 0.0000
960 DRY EYE 1 0.0000
961 FLUSHING 2 0.0000
962 HAEMOGLOBIN DECREASED 2 0.0000
963 INFLAMMATION 1 0.0000
964 TREATMENT NONCOMPLIANCE 1 0.0000
965 BLISTER 1 0.0000
966 CEREBROVASCULAR ACCIDENT 3 0.0000
967 ASTHMA 2 0.0000
968 HERPES ZOSTER 1 0.0000
969 EYE IRRITATION 1 0.0000
970 PRODUCT SUBSTITUTION ISSUE 1 0.0000
971 CATARACT 1 0.0000
972 IRRITABILITY 1 0.0000
973 NO ADVERSE EVENT 3 0.0000
974 BLOOD GLUCOSE INCREASED 3 0.0000
975 DEEP VEIN THROMBOSIS 1 0.0000
976 PRODUCT DOSE OMISSION 1 0.0000
977 SKIN BURNING SENSATION 1 0.0000
978 MOBILITY DECREASED 1 0.0000
979 BRONCHITIS 1 0.0000
980 CHRONIC KIDNEY DISEASE 1 0.0000
981 INCORRECT DOSE ADMINISTERED 3 0.0000
982 ARTHRITIS 1 0.0000
983 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
984 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
985 MUSCULOSKELETAL STIFFNESS 1 0.0000
986 HYPERSENSITIVITY 2 0.0000
987 CARDIAC DISORDER 1 0.0000
988 CHEST DISCOMFORT 1 0.0000
989 JOINT SWELLING 1 0.0000
990 DRUG DOSE OMISSION 1 0.0000
991 MYOCARDIAL INFARCTION 1 0.0000
992 ERYTHEMA 1 0.0000